Oxygen therapy during chemotherapy for colorectal cancer
Part of Cancer, Digestive system, Mental health clinical trials.
This trial tests whether breathing in extra oxygen (normobaric oxygen therapy) while receiving chemotherapy helps people with colorectal cancer feel better and respond better to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have colorectal cancer at stage II, III, or IV and are about to start standard chemotherapy.
- Your hemoglobin level is above 10 g/dL.
- You are generally able to care for yourself and are not confined to bed (ECOG score 0-2).
- You do not have severe heart or lung disease, uncontrolled diabetes, or other conditions that would make oxygen therapy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy can help shrink breast tumors more effectively. It is for women with triple-negative or HER2-positive breast cancer who are scheduled for neoadjuvant therapy.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This study tests whether short bursts of low oxygen (intermittent hypoxia) can help treat early-stage colorectal cancer. It's designed for people with stage I or II colorectal cancer who are otherwise healthy.
This trial tests an aerobic exercise plan during chemotherapy for people with stage II or III colon cancer. It compares different exercise approaches to see if exercise can be done safely and may improve how you tolerate treatment and recovery.
This trial tests putting a chemo drug (fluorouracil) directly into the colon through a tube. It's for people with colorectal cancer who are already getting other cancer treatment, to see if adding local chemo helps shrink the main tumor.
This trial tests two chemotherapy drugs, capecitabine alone or with oxaliplatin, in people aged 70 or older after surgery for stage III colorectal cancer. The goal is to find out which treatment works better to prevent cancer from coming back.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.